The Russian Ministry of Health reminded the record of two American drugs for the treatment of blood cancer. This was reported by the newspaper “Kommersant” (“Kommersant”).
Various blood cancer – we are talking about antitumor drugs used in the treatment of patients with revlimid and immovid. The rights of these drugs belong to the American pharmaceutical company Bristol-Myers Squibb, who left the Russian Federation.
A few years ago, these drugs were the best sold in the state supply segment, but now they lost their shares on the market for Russian generic.
March 14, reported to be in Russia Reclaimed record 31 Switzerland Pharmaceutical Company Sandoz. The reason for the recall was to update the drug portfolio.
Previous Russian Federation Government Simplified Record of maximum holiday prices for vital drugs.
What are you thinking?
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.